Ms. Varghese Presit joined the Company as a director in April 2026. Ms. Varghese Presti currently serves as Corporate Vice President and Chief Operating Officer of Microsoft's Health & Life Sciences organization, where she leads operational strategy and execution for a global, high-growth business. In this role, she has played a central role in advancing Microsoft's healthcare strategy, including operationalizing AI-powered clinical and agentic technologies that improve care delivery, workflow efficiency, and data-driven decision-making across health systems. Prior to her current role, Ms. Varghese Presti held leadership positions at several prominent healthcare and technology organizations, including Microsoft, Nuance, IBM Watson Health, athenahealth, and Pfizer. Her experience spans care delivery, health policy, life sciences, and enterprise technology, providing her with a cross-sector perspective on scaling innovation from concept to adoption. Ms. Varghese Presti brings extensive experience across the mergers and acquisitions lifecycle, including strategic diligence, post-acquisition integration, and portfolio scaling. At Microsoft, she has been closely involved in integration efforts following the acquisition of Nuance, aligning product, operational, and commercial capabilities. Previously, at IBM Watson Health, she led a life sciences portfolio built through multiple acquisitions and contributed to diligence efforts related to IBM's divestiture of Watson Health. Ms. Varghese Presti began her career as a pediatric nurse at Johns Hopkins, an experience that continues to inform her approach to healthcare innovation with a focus on patient-centered care. Ms. Varghese Presti is qualified to serve on our Board because of her extensive leadership experience in healthcare and technology, her expertise in scaling platforms and commercializing innovation, and her deep operational and strategic capabilities in complex, regulated environments.